GL1X · GenesisL1 explorer

MolNFT v1 · #88325 · protein

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

4CRA · Coagulation factor XI: “Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design”. X-ray diffraction, 2 ligands (XJ8, SO4), 2 pockets (best druggability 0.48). MolNFT v1 #88325 on…

PDB
4CRA
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor XI
EC
3.4.21.27
UniProt
P03951
Ligands
XJ8, SO4
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor XI (EC 3.4.21.27)protein23815% helix, 34% strandP03951

Ligands and binding sites

  • XJ8 · N-[(1S)-2-[(2-amino-5-quinolyl)methylamino]-1-benzyl-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11450.480.7823GOL, XJ8
21230.450.7820empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4CRA · Creating novel F1 inhibitors through fragment based lead generation and structure aided… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.